Keywords: valeant, sells, preclinical, assets, ardea, firm, pharmaceuticals

Valeant sells preclinical assets to Ardea

Article | 08 January 2007

US firm Valeant Pharmaceuticals International has sold certain of its discovery and preclinical assets to Ardea Biosciences. This includes the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Valeant Pharmaceuticals

Go to company listing